Iridex Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
38,273.00
42,814.00
41,757.00
46,158.00
41,593.00
42,600
Cost of Goods Sold (COGS) incl. D&A
19,702.00
21,425.00
21,553.00
24,866.00
24,286.00
25,145
Gross Income
18,571.00
21,389.00
20,204.00
21,292.00
17,307.00
17,455
SG&A Expense
16,411.00
18,802.00
19,649.00
23,268.00
28,515.00
30,323
EBIT
2,160.00
2,587.00
288.00
2,445.00
13,028.00
12,868
Unusual Expense
73.00
1,258.00
5.00
215.00
295.00
149
Non Operating Income/Expense
29.00
3.00
8.00
4.00
328.00
241
Pretax Income
2,262.00
1,332.00
291.00
2,656.00
12,995.00
12,776
Income Tax
31.00
8,706.00
183.00
9,057.00
128.00
37
Consolidated Net Income
2,231.00
10,038.00
474.00
11,713.00
12,867.00
12,813
Net Income
2,231.00
10,038.00
474.00
11,713.00
12,867.00
12,813
Net Income After Extraordinaries
2,231.00
10,038.00
474.00
11,713.00
12,867.00
12,813
Net Income Available to Common
2,231.00
10,038.00
474.00
11,713.00
12,867.00
12,813
EPS (Basic)
0.22
0.97
0.05
1.15
1.11
1.05
Basic Shares Outstanding
9,245.00
9,892.00
9,962.00
10,173.00
11,555.00
12,199
EPS (Diluted)
0.22
0.97
0.05
1.15
1.11
1.05
Diluted Shares Outstanding
10,104.00
10,357.00
10,128.00
10,173.00
11,555.00
12,199
EBITDA
2,650.00
3,007.00
810.00
1,797.00
12,170.00
12,059
Other Operating Expense
-
-
267.00
469.00
1,820.00
-

About Iridex

View Profile
Address
1212 Terra Bella Avenue
Mountain View California 94043
United States
Employees -
Website http://www.iridex.com
Updated 07/08/2019
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A.